Bibliography
- Boyer S. The use of computer models in pharmaceutical safety evaluation. Altern Lab Anim 2009;37(5):467-75
- Helgee EA, Carlsson L, Boyer S. A method for automated molecular optimization applied to Ames mutagenicity data. J Chem Inf Model 2009;49(11):2559-63
- Bercu JP, Morton SM, Deahl JT, In silico approaches to predicting cancer potency for risk assessment of genotoxic impurities in drug substances. Regul Toxicol Pharmacol 2010;57(2-3):300-6
- Yang C, Valerio LG Jr, Arvidson KB. Computational toxicology approaches at the US Food and Drug Administration. Altern Lab Anim 2009;37(5):523-31
- Valerio LG Jr, Yang C, Arvidson KB, A structural feature-based computational approach for toxicology predictions. Expert Opin Drug Metab Toxicol 2010;6(4):505-18
- Valerio LG Jr, Prous J, Valencia A, Computational Modeling for QT Prolongation: a Drug Cardiovascular Endpoint of Paramount Importance. In: Society of Toxicology, editor. The Toxicologist Annual Meeting of the Society of Toxicology. Oxford Journals; Washington, D.C, USA: 2011. p. 126
- Arvidson KB, Chanderbhan R, Muldoon-Jacobs K, Regulatory use of computational toxicology tools and databases at the United States food and drug administration's office of food additive safety. Expert Opin Drug Metab Toxicol 2010;6(7):793-6
- FDA. Guidance for Industry. Genotoxic and Carcinogenic Impurities in Drug Substances and Products: recommended Approaches. Draft Guidance. US Depart. Of Health and Human Services. Ed.: Office of Communications, Division of Drug Information, CDER, FDA; 2008; p. 1-13
- ICH. Final Concept Paper. M7: genotoxic Impurities. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use 2010. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Multidisciplinary/M7/M7_Final_Concept_Paper_June_2010.pdf [Cited 8 February 2011]
- DIA. DIA/FDA Quantitative Structure-Activity Relationship (Q)SAR Approaches to Assessing Genotoxic Impurities in Pharmaceuticals. Drug Information Agency; Rockville, MD USA: 2011
- Mostrag-Szlichtyng A, Zaldivar Comenges JM, Worth AP. Computational toxicology at the European commission's joint research centre. Expert Opin Drug Metab Toxicol 2010;6(7):785-92
- Hillebrecht A, Muster W, Brigo A, Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitations. Chem Res Toxicol 2011;24(6):843-54
- Valerio LG, Yang C, Arvidson KB, A structural feature-based computational approach for toxicology predictions. Expert Opin Drug Metab Toxicol 2010;6(4):505-18
- FDA. Advancing Regulatory Science at FDA. In: Department of Health and Human Services, Ed. Rockville, MD: FDA 2011:7-10. Available from: http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/default.htm
- FDA. Strategic Priorities. 2011-20155. Responding to the Public Health Challenges of the 21st Century. 2011. 2.0 Cross-Cutting Strategic Priorities. Available from: http://www.fda.gov/AboutFDA/ReportsManualsForms/Reports/ucm246737.htm [Cited 1 November 2011]